| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 07/13/2004 | US6762321 Amide compounds and use thereof |
| 07/13/2004 | US6762205 Phenyl sulfamate derivatives |
| 07/13/2004 | US6762204 Taxol enhancer compounds |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/08/2004 | WO2004056797A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056796A1 Preparation of heterocyclic ketones |
| 07/08/2004 | WO2004056795A1 A process for preparing duloxetine and intermediates for use therein |
| 07/08/2004 | WO2004056755A2 Compounds for the inhibition of non-proteolytic enzymes |
| 07/08/2004 | WO2004056747A1 Dhodh-inhibitors and method for their identification |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056735A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004051217A3 Process for synthesis bis-aryl diamidoxime compounds |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | WO2003062181A8 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 07/08/2004 | US20040133010 Photochromic reaction occurs in the crystalline state, especially in the single-crystalline state; does not need any dispersion medium |
| 07/08/2004 | US20040132960 Polymers having pendant nonlinear optical chromophores and electro-optic devices therefrom |
| 07/08/2004 | US20040132959 Organic compounds having a core-shell structure |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132786 Differential tumor cytotoxicity compounds and compositions |
| 07/08/2004 | US20040132784 1-optionally protected hydroxy-2-aminoalkylaryl compounds, especially in which the amino and hydroxy groups are joined by a carbonyl to form an oxazolidinone ring; immunosuppressants |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132775 cyclodehydrating an oxy-substituted phenylthiomethyl phenyl ketone in the presence of an acid activated clay or acid activated zeolite catalyst and in the presence of a suitable solvent, such as toluene |
| 07/08/2004 | US20040132769 Certain phenylacetic acids and derivatives |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/08/2004 | US20040132742 carboxamide derivatives, e.g., N-[4-Methoxy-3-(4-methylpiperazin-1-yl)phenyl]-N-methyl-4-phenylbenzamide and -Chlorobenzo[b]thiophene-2-carboxylic acid N-(4-methoxy-3-piperazin-1-ylphenyl)-N-methyl amide; 5HT6 receptor antagonists |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040131648 Nuclear hormone receptor compounds, products and methods employing same |
| 07/08/2004 | DE10196976T5 Durch reaktionskontrollierten Phasentransferkatalysator katalysiertes Oxidationsreaktionsverfahren By reaction controlled phase transfer catalyst catalyzed oxidation reaction process |
| 07/08/2004 | CA2510750A1 A process for preparing duloxetine and intermediates for use therein |
| 07/08/2004 | CA2509138A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/07/2004 | EP1435355A1 Stilbeneamine derivative and electrophotosensitive material using the same |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1012136B1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists |
| 07/07/2004 | CN1511148A Chloromethylation of thiophene |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/01/2004 | WO2004055023A1 Method for the decarboxylation of dicarboxylic acids |
| 07/01/2004 | WO2004055000A1 Multifunctional cationic photoinitiators, their preparation and use |
| 07/01/2004 | WO2004054999A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 07/01/2004 | WO2004054982A1 Biphenylcarboxamides |
| 07/01/2004 | WO2004024878A3 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | WO2003045878A8 2,w-diaminocarboxylic acid compounds |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | US20040127724 such as 3-aminomethyl-4-thiophen-2-yl-butyric acid; for treating epilepsy, neurodegenerative disorders, depression, anxiety, panic, pain, irritable bowel syndrome, and arthritis |
| 07/01/2004 | US20040127721 Process for the synthesis of bis-aryl diamidoxime compounds |
| 07/01/2004 | US20040127592 Mono-, oligo- and poly(3-alkynylthiophenes) and their use as charge transport materials |
| 07/01/2004 | US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent |
| 07/01/2004 | US20040127548 thiophene derivative paraciticides |
| 07/01/2004 | US20040127546 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127487 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
| 07/01/2004 | US20040127469 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/01/2004 | US20040127365 Arylphenyl-substituted cyclic ketoenols |
| 07/01/2004 | DE10260095A1 Preparation of cyclopenta-heterocycles, useful for preparing metallocene catalysts for olefin polymerization, by reacting heterocycle with unsaturated carboxylic acid in presence of strong acid and dehydrating agent |
| 07/01/2004 | DE10258098A1 Preparation of thiophene derivatives, used as intermediate for synthesis of e.g. Duloxetine, comprises hydrogenation of ketone compounds with enantiomer-enriched bidentate phosphorus-containing ligand |
| 07/01/2004 | CA2507629A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 06/30/2004 | EP1433779A1 Use of nitriles as inhibitors of non-proteolytic enzymes |
| 06/30/2004 | EP1433778A1 Use of nitriles as rotamase inhibitors |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/30/2004 | EP1432693A2 Mch receptor antagonists |
| 06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756343 Controlling rice paddy field weeds at low dosage dose; plant safening |
| 06/29/2004 | US6756342 Substituted thienocycloalk(en) ylamino -1,3,5-triazine |
| 06/29/2004 | US6756216 Batch processing using nucleophilic compound |
| 06/29/2004 | CA2133089C Novel cyclic amino acids and derivatives thereof |
| 06/24/2004 | WO2004053087A2 Nf-κb inhibitors |
| 06/24/2004 | WO2004052885A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/24/2004 | WO2004052879A1 Thiophenederivatives for the treatment of flavivirus infections |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052838A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 06/24/2004 | WO2004052816A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122102 compounds are potent ocular hypotensives, and are suitable for the management of glaucoma; they also are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases, gastrointestinal, reproduction disorders etc |
| 06/24/2004 | US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 06/24/2004 | US20040122079 (R)-thiophene-2,5-dicarboxylic acid 2-hydroxyamide 5-[(1-thiophen-2-yl-ethyl)-amide], e.g.: antiproliferative agents; anticarcinogenic agents; enzyme inhibitors of histonedeacetylases; colon, breast, lung, prostate, rectal, stomach, bladder cancers |
| 06/24/2004 | US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 06/24/2004 | US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040122007 1-aryl-2-hydroxyethyl amides as potassium channel openers |
| 06/24/2004 | US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease |
| 06/24/2004 | US20040121985 Useful as restenosis inhibitors; for reducing the level of protein geranylgeranylation in mammalian cells |
| 06/24/2004 | US20040119049 or semiconductors in electrooptical, electronic and electroluminescent devices |
| 06/24/2004 | DE10258588A1 Dicarboxylic acids (especially 3,4-ethylenedioxythiophene-2,5-dicarboxylic acid) are thermally decarboxylated in the solid state and/or in the presence of fluidized layer bodies |